Isomorphic Labs Seeks Funding at Valuation of $40 Billion

Isomorphic Labs, an AI-powered drug discovery startup spun out of Alphabet Inc.'s Google DeepMind, is in early talks to raise new funds at a valuation of at least $40 billion, according to people familiar with the effort. Bloomberg's Neil Campling has the details.